Antinuclear Antibody Test Market Regional Analysis:
North American Market Insights
By 2035, North American region is anticipated to capture lucrative antinuclear antibody test market share of 40.6%, attributed majorly to the growing geriatric population and rising cases of autoimmune diseases. Based on the report provided by the American Autoimmune Related Diseases Association (AARDA), it was stated that over 100 types of autoimmune diseases are found in the region while 50 million Americans suffer from some sort of autoimmune disease. Furthermore, rising cases of arthritis in North America are also projected to hike the growth of the market. According to the report published by the Centers for Disease Control and Prevention, the number of arthritis patients is projected to reach 78 million adults .
APAC Market Market Insights
Furthermore, the market is anticipated to grow rapidly in the Asia Pacific region during the forecast period, attributed to similar factors which are increasing cases of autoimmune diseases, and an increment in the geriatric population. Additionally, escalating government initiatives in the healthcare sector can also be the major market growth factor.
